Changes in the composition and metabolism of arterial collagens during the development of pulmonary hypertension in rabbits.
Increased pulmonary artery pressure is known to result in enhanced collagen deposition in the pulmonary artery. Here we investigate how changes in collagen metabolism may bring about this increased deposition in the pulmonary artery of animals with pulmonary hypertension induced by bleomycin. Rabbits were injected intratracheally with bleomycin sulfate or with saline. After 14 days the animals were injected with L-[U-14C]proline plus a "flooding" dose of unlabeled proline. Uptake into arterial collagens and release of labeled hydroxyproline were then measured after 2.5 h. The relative amounts of types I and III collagens were assessed from the levels of cyanogen-bromide-derived peptides alpha 1(I)CB8 and alpha 1(III)CB5, respectively, after sodium dodecyl sulfate polyacrylamide gel electrophoresis. Collagen synthesis rates of about 3%/day were found in the control pulmonary artery and aorta, and about one-half of the newly synthesized collagen was degraded rapidly. Fourteen days after bleomycin, there was a fivefold increase in collagen synthesis rate (p less than 0.01) and a marked decrease in the percentage of newly synthesized collagen degraded rapidly. There was no change in collagen metabolism in the aorta of these animals. Pulmonary artery collagen from control rabbits consisted of 26.5 +/- 1.0% type III collagen. There was no change in composition in bleomycin-treated animals. This study demonstrates quite rapid turnover rates for collagen in normal blood vessels. Our results also indicate that remodeling of arterial connective tissue matrix during pulmonary hypertension involves marked but commensurate increases in type I and III collagens brought about by changes in both synthesis and degradative processes.
Department of Thoracic Medicine, University of London, England.
J E
JE
Bishop
D
D
Guerreiro
G J
GJ
Laurent
D000818:Animals; D001011:Aorta / Q000032:analysis / Q000378:metabolism* / Q000473:pathology; D001761:Bleomycin / Q000633:toxicity; D003094:Collagen / Q000032:analysis / Q000378:metabolism*; D004591:Electrophoresis, Polyacrylamide Gel; D006909:Hydroxyproline / Q000032:analysis / Q000378:metabolism; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D008297:Male; D011392:Proline / Q000008:administration & dosage; D011651:Pulmonary Artery / Q000032:analysis / Q000378:metabolism* / Q000473:pathology; D011817:Rabbits; D013053:Spectrophotometry; D013997:Time Factors
D001761:Bleomycin; D003094:Collagen; D011392:Proline; D006909:Hydroxyproline